Inhibition of receptor‐binding domain—ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS‐CoV‐2 vaccines - Silva, Valéria O.; Yamashiro, Rosemeire; Ahagon, Cintia M.; Campos, Ivana B.; de Oliveira, Isabela P.; de Oliveira, Elaine L.; López‐Lopes, Giselle I. S.; Matsuda, Elaine M.; Castejon, Marcia J.; de Macedo Brígido, Luís F. (Journal of medical virology, 2022)
Keywords: ACE2; Angiotensin; Angiotensin-Converting Enzyme 2; Angiotensins; Antibodies; Antibodies, Neutralizing; Antibodies, Viral; Antibody response; Binding; ChAdOx1 nCoV-19; Clinical trials; Conversion; Coronaviruses; COVID-19 - prevention & control; COVID-19 Vaccines; COVID‐19; Domains; Enzymes; Evaluation; Humans; Infections; Laboratories; Neutralization; Receptors; Receptor‐Binding Domain; Respiratory diseases; SARS-CoV-2; Severe acute respiratory syndrome; Severe acute respiratory syndrome coronavirus 2; Short Communication; Spike Glycoprotein, Coronavirus; Vaccine; Vaccine efficacy; Vaccines; Viral diseases; Viral Neutralization; Virology; COVID-19; Receptor-Binding Domain; Antibodies; SARS-CoV-2; Vaccine; Viral Neutralization